{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:23:16Z","timestamp":1794248596011,"version":"4.9.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Traditional Chinese Medicine Science and Technology Project","award":["2022ZB285"],"award-info":[{"award-number":["2022ZB285"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,21]]},"abstract":"<jats:p>\n                    This study evaluates the therapeutic effect of acitretin capsules combined with a cooling blood and detoxifying formula (CBDF) on psoriasis hemorrhagic fever and its impact on the gut microbiota (GM). Seventy patients diagnosed with psoriasis hemorrhagic fever between January 2022 and April 2023 were divided into 2 groups: an experimental group (EG) treated with acitretin capsules and the CBDF, and a control group treated with acitretin capsules alone. The study assessed immune inflammatory responses, symptom improvement, traditional Chinese medicine symptom scores, and changes in GM diversity and abundance before and after treatment. After 2 months, the EG showed significant reductions in interleukin-2 receptor levels (from 813.2\u2005\u00b1\u2005201.5\u2013402.3\u2005\u00b1\u2005111.2\u2009mg\/L) and interleukin-6 (from 8.4\u2005\u00b1\u20053.1\u20133.8\u2005\u00b1\u20051.7 pg\/mL). The quality of life index improved by 6.12 points in the EG, which was significantly better than the control group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). PASI scores decreased in both groups, with the EG showing greater improvement (PASI before treatment: 23.1\u2005\u00b1\u20054.3; after 1 month: 15.6\u2005\u00b1\u20053.8; after 2 months: 10.4\u2005\u00b1\u20053.3). The EG also showed a significant increase in GM diversity after treatment (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Acitretin capsules combined with the CBDF is effective in treating psoriasis hemorrhagic fever and positively affects the GM, offering a potential new treatment approach.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000041502","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:04:57Z","timestamp":1743033897000},"page":"e41502","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of the therapeutic effect of acitretin capsules combined with cooling blood and detoxifying formula on psoriasis hemorrhagic fever and its impact on the gut microbiota of patients"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5606-3477","authenticated-orcid":false,"given":"Mengyun","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People\u2019s Hospital, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People\u2019s Hospital, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People\u2019s Hospital, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Feng","family":"Zha","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People\u2019s Hospital, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People\u2019s Hospital, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People\u2019s Hospital, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261109","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40257-021-00654-z","article-title":"Clinical course and characteristics of generalized pustular psoriasis.","volume":"23","author":"Choon","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"R2-20261109","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/1346-8138.15958","article-title":"Clinical analysis of generalized pustular psoriasis in Chinese patients: a retrospective study of 110 patients.","volume":"48","author":"Zheng","year":"2021","journal-title":"J Dermatol"},{"key":"R3-20261109","first-page":"42","article-title":"Study on the rule of traditional Chinese medicine in treating psoriasis with blood heat syndrome based on data mining.","volume":"5","author":"Yu","year":"2023","journal-title":"MEDS Chin Med"},{"key":"R4-20261109","first-page":"26","article-title":"The understanding and treatment of common psoriasis in Chinese medicine.","volume":"5","author":"Qi","year":"2023","journal-title":"MEDS Chin Med"},{"key":"R5-20261109","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/exd.14835","article-title":"Transcriptomic responses of peripheral blood mononuclear cells to cyclosporin and etanercept in a female infant with juvenile generalized pustular psoriasis.","volume":"32","author":"Lin","year":"2023","journal-title":"Exp Dermatol"},{"key":"R6-20261109","doi-asserted-by":"crossref","first-page":"378","DOI":"10.25259\/IJDVL_1054_2021","article-title":"Correlation of IL36RN and CARD14 mutations with clinical manifestations and laboratory findings in patients with generalised pustular psoriasis.","volume":"89","author":"Trai","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R7-20261109","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1080\/09546634.2022.2089327","article-title":"Efficacy of adalimumab in pediatric generalized pustular psoriasis: case series and literature review.","volume":"33","author":"Du","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"R8-20261109","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/1381612828666220118121536","article-title":"Therapeutic application of microsponges-based drug delivery systems.","volume":"28","author":"Rahman","year":"2022","journal-title":"Curr Pharm Des"},{"key":"R9-20261109","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5530\/ijper.58.1.3","article-title":"Nanostructured lipid carriers: a potential era of drug delivery systems.","volume":"58","author":"Chinthaginjala","year":"2024","journal-title":"Ind J Pharm Edu Res"},{"key":"R10-20261109","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/ijd.15733","article-title":"Therapeutic benefits of natural oils along with permeation enhancing activity.","volume":"61","author":"Amra","year":"2022","journal-title":"Int J Dermatol"},{"key":"R11-20261109","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.52711\/0974-360X.2022.00715","article-title":"Nanosponges: advancement in nanotherapeutics.","volume":"15","author":"Verma","year":"2022","journal-title":"Res J Pharm Technol"},{"key":"R12-20261109","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1386207326666230914103714","article-title":"Role of bioactive compounds, novel drug delivery systems, and polyherbal formulations in the management of rheumatoid arthritis.","volume":"27","author":"Rana","year":"2024","journal-title":"Comb Chem High Throughput Screen"},{"key":"R13-20261109","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/00325481.2023.2285730","article-title":"Generalized pustular psoriasis: practical recommendations for Spanish primary care and emergency physicians.","volume":"135","author":"Rivera-Diaz","year":"2023","journal-title":"Postgrad Med"},{"key":"R14-20261109","first-page":"33","article-title":"Multiple sclerosis in a patient with familial Mediterranean fever and psoriasis: a case report and review of the literature.","volume":"7","author":"Song\u00fcl","year":"2023","journal-title":"Arel \u00dcniversitesi Sa\u011flik Bilimleri Dergisi"},{"key":"R15-20261109","first-page":"753","article-title":"Generalized pustular psoriasis: overview of the status quo and results of a panel discussion.","volume":"20","author":"Reich","year":"2022","journal-title":"JDDG"},{"key":"R16-20261109","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1346-8138.16691","article-title":"English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).","volume":"50","author":"Saeki","year":"2023","journal-title":"J Dermatol"},{"key":"R17-20261109","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/1744666X.2023.2195165","article-title":"Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis.","volume":"19","author":"Burden","year":"2023","journal-title":"Exp Rev Clin Immunol"},{"key":"R18-20261109","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1574886315666201026125149","article-title":"Severe pancytopenia following single dose methotrexate in psoriasis: a rare and potentially lethal manifestation.","volume":"16","author":"Singh","year":"2021","journal-title":"Curr Drug Saf"},{"key":"R19-20261109","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/JD9.0000000000000275","article-title":"Characterization of generalized pustular psoriasis in Northwest China: a single-center retrospective study.","volume":"5","author":"Li","year":"2022","journal-title":"Int J Dermatol Venereol"},{"key":"R20-20261109","first-page":"25","article-title":"Case study and patient counseling for elderly patient on psoriasis vulgaris.","volume":"10","author":"Mallika","year":"2022","journal-title":"Int J Pharm Res Life Sci"},{"key":"R21-20261109","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/1744666X.2021.1961580","article-title":"Generalized pustular psoriasis: current management status and unmet medical needs in Japan.","volume":"17","author":"Komine","year":"2021","journal-title":"Exp Rev Clin Immunol"},{"key":"R22-20261109","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/exd.14805","article-title":"Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: should they be the same or different entities?","volume":"32","author":"Chularojanamontri","year":"2023","journal-title":"Exp Dermatol"},{"key":"R23-20261109","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/1346-8138.16271","article-title":"Flare\u2010up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination.","volume":"49","author":"Yatsuzuka","year":"2022","journal-title":"J Dermatol"},{"key":"R24-20261109","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bjd\/ljad083","article-title":"Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial.","volume":"189","author":"Warren","year":"2023","journal-title":"Br J Dermatol"},{"key":"R25-20261109","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/cdr.cdr_45_21","article-title":"Ulcerations in chronic plaque psoriasis: a diagnostic clue for acute methotrexate toxicity.","volume":"7","author":"Bhakthavatsalam","year":"2023","journal-title":"Clin Dermatol Rev"},{"key":"R26-20261109","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/1346-8138.16551","article-title":"Real\u2010world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis.","volume":"50","author":"Miao","year":"2023","journal-title":"J Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:00:26Z","timestamp":1794247226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041502","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,21]]}}}